The Cancer Immunotherapy Consortium has served the cancer immunotherapy community since 2002 and has made significant contributions to progress in the field. Through seminars, workshops, working groups, and online consensus-building projects supported by immunological and clinical data from cancer immunotherapy trials, the Consortium works to address several of the key issues facing the cancer immunotherapy field.
Immune Assay Proficiency/Harmonization Panels
Meetings & Workshops
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Dr. Lieping Chen's work helped pave the way for the development of the PD-1/PD-L1 checkpoint immunotherapies that have revolutionized cancer care.
Scientist Thomas Tan discusses his preparation for the Bigfoot 100K and his motivation for fundraising for cancer immunotherapy research.